Tyrosine hydroxylase polymorphisms and manic-depressive illness

The effect of 5-HTTLPR and a serotonergic multi-marker score on amygdala, prefrontal and anterior cingulate cortex reactivity and habituation in a large, healthy fMRI cohort.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2018

[Telephone coaching for depression].

Der Nervenarzt·2017

Metabolic vs. hedonic obesity: a conceptual distinction and its clinical implications.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2015

The QT interval and the atypical antipsychotic, sertindole.

International journal of psychiatry in clinical practice·2014

Genetic risk prediction and neurobiological understanding of alcoholism.

Translational psychiatry·2014

Genome-wide association of mood-incongruent psychotic bipolar disorder.

Translational psychiatry·2012

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Genomic landscape of Mexican patients with maturity onset diabetes of the young: beyond mutations in MODY-known genes.

Frontiers in endocrinology·2026

Linking SIRT1 gene variation and protein levels to the pathophysiology of type 2 diabetes.

Molecular biology research communications·2026

Pharmacogenetic analyses in people with dementia in Northeast Germany.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis.

Frontiers in immunology·2026

Retraction Note: Micropropagation and assessment of genetic fidelity of Dendrocalamus strictus (Roxb.) nees using RAPD and ISSR markers.

3 Biotech·2026

Distribution of ST116 carbapenem-resistant Citrobacter freundii in public genomes and characterization of a triple-carbapenemase-producing strain.

Frontiers in cellular and infection microbiology·2026

Related Experiment Videos

Tyrosine hydroxylase polymorphisms and manic-depressive illness

Related Concept Videos

The effect of 5-HTTLPR and a serotonergic multi-marker score on amygdala, prefrontal and anterior cingulate cortex reactivity and habituation in a large, healthy fMRI cohort.

[Telephone coaching for depression].

Metabolic vs. hedonic obesity: a conceptual distinction and its clinical implications.

The QT interval and the atypical antipsychotic, sertindole.

Genetic risk prediction and neurobiological understanding of alcoholism.

Genome-wide association of mood-incongruent psychotic bipolar disorder.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Genomic landscape of Mexican patients with maturity onset diabetes of the young: beyond mutations in MODY-known genes.

Linking <i>SIRT1</i> gene variation and protein levels to the pathophysiology of type 2 diabetes.

Pharmacogenetic analyses in people with dementia in Northeast Germany.

Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis.

Retraction Note: Micropropagation and assessment of genetic fidelity of <i>Dendrocalamus strictus</i> (Roxb.) nees using RAPD and ISSR markers.

Distribution of ST116 carbapenem-resistant <i>Citrobacter freundii</i> in public genomes and characterization of a triple-carbapenemase-producing strain.

Related Experiment Videos

Tyrosine hydroxylase polymorphisms and manic-depressive illness

Related Concept Videos

Related Articles